Introduction

Approval number: State Drug Licence H20059065

Stength: 1.5ml:75mg （with one bottle of solvent in one package）

[Ingredients] The main ingredient of this product is an amsacrine.

[Indications] It is effective in acute leukaemia and malignant lymphoma. There is no obvious cross-resistance to 

anthracycline and cytarabine-resistant patients, and some patients are still effective.